T

Trinity Biotech plc
D

TRIB

0.68500
USD
-0.05
(-6.16%)
مغلق
حجم التداول
2,500
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
12,762,933
أصول ذات صلة
A
AUPH
-0.19500
(-2.36%)
8.07000 USD
C
CYCC
-0.01000
(-0.69%)
1.44000 USD
D
DARE
-0.01000
(-0.34%)
2.89000 USD
M
MNKD
-0.10500
(-2.49%)
4.12000 USD
V
VSTM
0.83500
(11.16%)
8.31500 USD
X
XOMA
-0.495
(-1.97%)
24.650 USD
المزيد
الأخبار المقالات

العنوان: Trinity Biotech plc

القطاع: Healthcare
الصناعة: Medical Devices
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.